🇺🇸 FDA
Pipeline program

CD19 targeted CAR-T cells

PBC054

Phase 1 mab active

Quick answer

CD19 targeted CAR-T cells for SLE (Systemic Lupus) is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
SLE (Systemic Lupus)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials